CELEBRATING 24 YEARS IN BUSINESS OVER 300,000 CLIENTS REPRESENTED
If you have an outstanding warrant in one of the following greater Houston area courts and feel you may be a part of the upcoming Great Texas Warrant Roundup we would like to help. The jurisdictions include: Houston Municipal Court, HCJP 1-1, HCJP 1-2, HCJP 3-1, HCJP 4-1, HCJP 4-2, HCJP 5-1, HCJP 5-2, HCJP 7-2, HCJP 8-1, HCJP 8-2, Jersey Village Municipal Court, Sugarland Municipal Court, Stafford Municipal Court, Missouri City Municipal Court, Pasadena Municipal Court, City of South Houston Municipal Court and Baytown Municipal Court.
The theory behind the all-metal hip implant was to allow those younger hip implant recipient patients to be able to go for a longer period of time before they were required to undergo revision surgery. The prior hip implant designs were primarily made from ceramic and polyethylene, and while these materials exhibited a reasonable success rate, they simply did not last long enough, with a typical length of time before revision surgery being approximately 8-10 years. The all-metal hip implants were expected to last almost double that amount of time, making them an exciting, innovative new development in hip implants. Problems soon began to arise with the metal-on-metal hip implants, with several models being recalled due to the risk of metallosis.
As one more in a long line of metal-on-metal hip implants to be plagued with recipient problems, the Biomet M2A Magnum first became available in October of 2004. The design of the Biomet M2A was meant to maximize mobility, minimize friction and offer a variety of size ranges to allow surgeons to more precisely fit the implant to the specific anatomy of each patient. Unfortunately, Biomet’s design has been found to have many of the same risks as other metal-on-metal hip implants such as metallosis, nerve and tissue damage in the area surrounding the implant, bone loss and loosening of the device which contributes to hip dislocation.
DePuy Orthopedics, along with their parent company, Johnson & Johnson, issued a recall of their ASR XL Acetabular Hip System, along with the ASR Hip Resurfacing System in August of 2010. This recall was implemented following a flurry of adverse event reports among recipients of one of these two hip implants. At the time of the recall DePuy and Johnson and Johnson acknowledged that the ASR XL and the ASR Hip Resurfacing System had a higher-than-expected rate of failure—as much as 12% within a short time after implantation. At the time of the recall, DePuy stated that the ASR could loosen or misalign and that recipients of the ASR were at a higher risk for infection, bone fracture, dislocation, metallosis, metal toxicity and pain.
WARNING: Do not send any information in any email through this website if you consider the information confidential or privileged.
STARS ON YELP WITH OVER 400 REVIEWS*
*AS OF 2024
TOP 10 VERDICT IN TEXAS* 2022
*BY TOPVERDICT.COM
TOP 100 NATIONAL TRIAL LAWYER* 2013-2024
*BY THE NATIONAL TRIAL LAWYERS
AVVO CLIENT'S CHOICE AWARD* 2016, 2017, 2019-2024
*GIVEN BY AVVO
AMERICAN ASSOCIATION OF JUSTICE 2013-2024
*GRANTED BY THE AAJ